Ann: Conference Call Details - Phase 2 Clinical Trial Results, page-11

No - in essence they have halted all further research on any products within their pipeline - including the ocular stuff.

Given the news is very recent, no decisions or determination has been made around a way forward.

They did advise that at this point they have not decided to wind the company up......not surprising really given this news is fresh off the print. 

There immediate focus is to halt all activities with partners etc.

No telling what will happen from here.........